Not Signed In - FDA Standards For Levothyroxine Bioequivalence, Substitution May Lead To Adverse Effects
Mon, 09 Oct 2006 07:00 AM EST
... Levothyroxine sodium (LT4), marketed as Unithroid, Synthroid, Levoxyl, and Levothroid, is the principal form of thyroid hormone replacement taken by 13 million Americans. The FDA's current system governing dispensing and substitution of the currently available eight proprietary and generic levothyroxine preparations is confusing for physicians, patients, and pharmacists. [click link for full article] ...
Related Topics
- Lead Poisoning
- Lead
- Levothyroxine
- Side effects and adverse reactions to medication treatments
- Blood Lead Levels
- Tacrolimus ointment
- Hepatitis A Vaccine
- Laboratory Guidelines And Standards
- Vaccine Identification Standards
- Thalidomide
- Poisoning
- Levothyroxine Injection
- Yohimbe
- Pimecrolimus Cream 1%
- Vaccine Safety and Adverse Event Reports
- Metoclopramide Oral Solution
- Mammography
- Usher Syndrome: New Insights Lead to Earlier Treatment
- Deformity of the hand or arm, mild to severe, which can lead to contractures
- Carcinogens
email this page
print this page
bookmark this page
feedback on this page
